14-23413897-C-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_000257.4(MYH7):c.5656-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000257.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251402Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135884
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461892Hom.: 0 Cov.: 33 AF XY: 0.0000426 AC XY: 31AN XY: 727246
GnomAD4 genome AF: 0.000105 AC: 16AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74352
ClinVar
Submissions by phenotype
not specified Benign:2
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Variant summary: MYH7 c.5656-4G>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 6.4e-05 in 251402 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in MYH7 causing Hypertrophic Cardiomyopathy (6.4e-05 vs 0.0013), allowing no conclusion about variant significance. c.5656-4G>A has been reported in the presumed heterozygous state with or without other variants in the literature in individuals affected with clinical features of Hypertrophic Cardiomyopathy and or dilated cardiomyopathy (example, Jaaskelainen_2019, Lu_2018, Zhang_2024) without strong evidence for causality. These report(s) do not provide unequivocal conclusions about association of the variant with Hypertrophic Cardiomyopathy. Co-occurrences with other pathogenic variant(s) have been reported (MYH7 c.428G>A, p.Arg143Gln), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30775854, 30165862, 37907184). ClinVar contains an entry for this variant (Variation ID: 516360). Based on the evidence outlined above, the variant was classified as likely benign. -
Cardiomyopathy Benign:2
- -
- -
Congenital myopathy with fiber type disproportion;C1834481:Dilated cardiomyopathy 1S;C1842160:Myosin storage myopathy;C1850709:Myopathy, myosin storage, autosomal recessive;C3495498:Hypertrophic cardiomyopathy 1;C4552004:MYH7-related skeletal myopathy Benign:1
- -
Hypertrophic cardiomyopathy Benign:1
- -
MYH7-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at